{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:56:06Z","timestamp":1790744166749,"version":"4.1.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    We describe a novel, severe autoinflammatory syndrome characterized by neuroinflammation, systemic autoinflammation, splenomegaly, and anemia (NASA) caused by bi-allelic mutations in\n                    <jats:italic>IRAK4<\/jats:italic>\n                    . IRAK-4 is a serine\/threonine kinase with a pivotal role in innate immune signaling from toll-like receptors and production of pro-inflammatory cytokines. In humans, bi-allelic mutations in\n                    <jats:italic>IRAK4<\/jats:italic>\n                    result in IRAK-4 deficiency and increased susceptibility to pyogenic bacterial infections, but autoinflammation has never been described. We describe 5 affected patients from 2 unrelated families with compound heterozygous mutations in\n                    <jats:italic>IRAK4<\/jats:italic>\n                    (c.C877T (p.Q293*)\/c.G958T (p.D320Y); and c.A86C (p.Q29P)\/c.161\u00a0+\u00a01G&amp;gt;A) resulting in severe systemic autoinflammation, massive splenomegaly and severe transfusion dependent anemia and, in 3\/5 cases, severe neuroinflammation and seizures. IRAK-4 protein expression was reduced in peripheral blood mononuclear cells (PBMC) in affected patients. Immunological analysis demonstrated elevated serum tumor necrosis factor (TNF), interleukin (IL) 1 beta (IL-1\u03b2), IL-6, IL-8, interferon \u03b12a (IFN-\u03b12a), and interferon \u03b2 (IFN-\u03b2); and elevated cerebrospinal fluid (CSF) IL-6 without elevation of CSF IFN-\u03b1 despite perturbed interferon gene signature. Mutations were located within the death domain (DD; p.Q29P and splice site mutation c.161\u00a0+\u00a01G&amp;gt;A) and kinase domain (p.Q293*\/p.D320Y) of IRAK-4. Structure-based modeling of the DD mutation p.Q29P showed alteration in the alignment of a loop within the DD with loss of contact distance and hydrogen bond interactions with IRAK-1\/2 within the myddosome complex. The kinase domain mutation p.D320Y was predicted to stabilize interactions within the kinase active site. While precise mechanisms of autoinflammation in NASA remain uncertain, we speculate that loss of negative regulation of IRAK-4 and IRAK-1; dysregulation of myddosome assembly and disassembly; or kinase active site instability may drive dysregulated IL-6 and TNF production. Blockade of IL-6 resulted in immediate and complete amelioration of systemic autoinflammation and anemia in all 5 patients treated; however, neuroinflammation has, so far proven recalcitrant to IL-6 blockade and the janus kinase (JAK) inhibitor baricitinib, likely due to lack of central nervous system penetration of both drugs. We therefore highlight that bi-allelic mutation in\n                    <jats:italic>IRAK4<\/jats:italic>\n                    may be associated with a severe and complex autoinflammatory and neuroinflammatory phenotype that we have called NASA (neuroinflammation, autoinflammation, splenomegaly and anemia), in addition to immunodeficiency in humans.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2023.1231749","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T12:42:54Z","timestamp":1694004174000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4"],"prefix":"10.3389","volume":"14","author":[{"given":"Samantha","family":"Cooray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Price-Kuehne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebun","family":"Omoyinmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Burleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly C.","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangdun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad W.","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Torpiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Gagunashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Bellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Sancho-Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jethro A.","family":"Herberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshitij","family":"Mankad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Kaliakatsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen J. J.","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Eleftheriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00344","article-title":"Monogenic autoinflammatory diseases with mendelian inheritance: Genes, mutations, and genotype\/phenotype correlations","volume":"8","author":"Martorana","year":"2017","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/imr.12606","article-title":"The family of the interleukin-1 receptors","volume":"281","author":"Boraschi","year":"2018","journal-title":"Immunol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1097-2765(03)00053-4","article-title":"Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members","volume":"11","author":"Janssens","year":"2003","journal-title":"Mol Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nature09121","article-title":"Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR\/IL-1R signalling","volume":"465","author":"Lin","year":"2010","journal-title":"Nature."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.022392","article-title":"An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4","volume":"284","author":"Motshwene","year":"2009","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses","volume":"434","author":"Honda","year":"2005","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070628","article-title":"Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity","volume":"204","author":"Ku","year":"2007","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.1081902","article-title":"Pyogenic bacterial infections in humans with IRAK-4 deficiency","volume":"299","author":"Picard","year":"2003","journal-title":"Science."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181fd8ec3","article-title":"Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency","volume":"89","author":"Picard","year":"2010","journal-title":"Med (Baltimore)."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600583","article-title":"Selective IRAK4 inhibition attenuates disease in murine lupus models and demonstrates steroid sparing activity","volume":"198","author":"Dudhgaonkar","year":"2017","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0433-8","article-title":"IRAK4 inhibition: a promising strategy for treating RA joint inflammation and bone erosion","volume":"18","author":"Umar","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061374","article-title":"Toll-like receptor signaling in the establishment and function of the immune system","volume":"10","author":"Aluri","year":"2021","journal-title":"Cells."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26452","article-title":"TLR8\/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins","volume":"97","author":"Fejtkova","year":"2022","journal-title":"Am J Hematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR","volume":"10","author":"Yang","year":"2015","journal-title":"Nat Protoc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.124","article-title":"Next-generation diagnostics and disease-gene discovery with the Exomiser","volume":"10","author":"Smedley","year":"2015","journal-title":"Nat Protoc"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat Methods"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1845","article-title":"A fast procedure for the detection of defects in Toll-like receptor signaling","volume":"118","author":"von Bernuth","year":"2006","journal-title":"Pediatrics."},{"key":"B19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jaci.2019.05.026","article-title":"Janus kinase 1\/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation","volume":"144","author":"Mulhern","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol Syst Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat Methods"},{"key":"B23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2006.11.001","article-title":"Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine\/threonine kinase with tyrosine as a gatekeeper","volume":"14","author":"Wang","year":"2006","journal-title":"Structure."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066856","article-title":"The PyRosetta Toolkit: a graphical user interface for the Rosetta software suite","volume":"8","author":"Adolf-Bryfogle","year":"2013","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c02559","article-title":"Unraveling the tomaralimab epitope on the toll-like receptor 2 via molecular dynamics and deep learning","volume":"7","author":"Ahmad","year":"2022","journal-title":"ACS Omega."},{"key":"B27","volume-title":"Molecular operating environment (MOE), 2020.09","year":"2020"},{"key":"B28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/rheumatology\/keu035","article-title":"IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease","volume":"44","author":"Ku","year":"2007","journal-title":"J Med Genet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu035","article-title":"Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo","volume":"53","author":"Wright","year":"2014","journal-title":"Rheumatol (Oxford)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049771","article-title":"Molecular evolution and structural features of IRAK family members","volume":"7","author":"Gosu","year":"2012","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1038\/srep05748","article-title":"Structural dynamic analysis of apo and ATP-bound IRAK4 kinase","volume":"4","author":"Gosu","year":"2014","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220170","article-title":"Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia","volume":"220","author":"Garcia-Garcia","year":"2023","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s10875-022-01369-4","article-title":"Inherited IRAK-4 deficiency in acute human herpesvirus-6 encephalitis","volume":"43","author":"Tepe","year":"2023","journal-title":"J Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.06.016","article-title":"Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children","volume":"145","author":"Caserta","year":"2004","journal-title":"J Pediatr"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01074-8","article-title":"Listeria monocytogenes meningoencephalitis due to IRAK4 deficiency","volume":"41","author":"Liu","year":"2021","journal-title":"J Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00885-5","article-title":"IRAK4 deficiency presenting with anti-NMDAR encephalitis and HHV6 reactivation","volume":"41","author":"Nishimura","year":"2021","journal-title":"J Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-846428","article-title":"Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques","volume":"132","author":"Nellan","year":"2018","journal-title":"Blood."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01500-z","article-title":"JAK inhibition in Aicardi-Gouti\u00e8res syndrome: a monocentric multidisciplinary real-world approach study","volume":"43","author":"Fr\u00e9mond","year":"2023","journal-title":"J Clin Virol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2031081","article-title":"JAK inhibition in the aicardi-goutieres syndrome","volume":"383","author":"Neven","year":"2020","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12974-019-1565-6","article-title":"Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro","volume":"16","author":"Gavegnano","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2001362","article-title":"Janus kinase inhibition in the aicardi-goutieres syndrome","volume":"383","author":"Vanderver","year":"2020","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.5077","article-title":"Assessment of clinical response to janus kinase inhibition in patients with familial chilblain lupus and TREX1 mutation","volume":"155","author":"Zimmermann","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/art.42087","article-title":"The 2021 european alliance of associations for rheumatology\/american college of rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE\/PRAAS, SAVI, and AGS","volume":"74","author":"Cetin Gedik","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70243-X","article-title":"Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study","volume":"9","author":"Hutchinson","year":"2010","journal-title":"Lancet Neurol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.1182\/blood-2018-99-117725","article-title":"Successful Treatment with Intrathecal Tocilizumab(IL-6 antibody) for 2 Cases of Graft-Versus Host Disease of the Central Nervous System after a Second Allogeneic HSCT from Haploidentical Donor","volume":"132","author":"Gui","year":"2018","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/jb\/mvm234","article-title":"IRAK-4-dependent degradation of IRAK-1 is a negative feedback signal for TLR-mediated NF-kappaB activation","volume":"143","author":"Kubo-Murai","year":"2008","journal-title":"J Biochem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1231749\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T12:42:57Z","timestamp":1694004177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1231749\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2023.1231749"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1231749","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"article-number":"1231749"}}